Theodore B. Lundberg Form 4 AdaptHealth / Theodore B. Lundberg ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lundberg Theodore B.

(Last) (First) (Middle)

C/O ADAPTHEALTH CORP.

220 W. GERMANTOWN PIKE, SUITE 250

(Street)

PLYMOUTH MEETING PA 19462

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/22/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/22/2022		A		9,321(1)	A	$0	13,830	D
Common Stock								6,680,833	I	See footnote(2)
Common Stock								634,347	I	See footnote(3)
Common Stock								2,142,163	I	See footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock to the Reporting Person, a director of the Issuer. The proceeds of any sale of these shares will be transferred to Peloton Equity, LLC and as such, the Reporting Person disclaims ownership of such shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

2. Shares held by Peloton AeroCare SPV I, L.P. ("Peloton AeroCare I"). Peloton Equity GP, LLC ("Peloton Equity GP") is the general partner of Peloton AeroCare I. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton AeroCare I except to the extent of his pecuniary interest therein, if any. Includes 3,214,007 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.

3. Shares held by Peloton AeroCare SPV II, L.P. ("Peloton AeroCare II"). Peloton Equity GP is the general partner of Peloton AeroCare II. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton AeroCare II except to the extent of his pecuniary interest therein, if any. Includes 306,087 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.

4. Shares held by Peloton Equity I, L.P. ("Peloton Equity I"). Peloton Equity GP is the general partner of Peloton Equity I. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton Equity I except to the extent of his pecuniary interest therein, if any. Includes 1,033,644 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.

	/s/ Theodore B. Lundberg***	06/24/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.